Levothyroxine Sodium
NDC 63323-895, Levothyroxine Sodium, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-895
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210632
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM100 ug/mL
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-895-10 | 63323089510 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-895-10) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/08f4b1f8-6807-47e7-bef8-8d1972aa0557Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-895
Use it
Look up 63323-895 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.